Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Cash from Investing Activities: 2016-2024

Historic Cash from Investing Activities for Krystal Biotech (KRYS) over the last 9 years, with Dec 2024 value amounting to -$163.4 million.

  • Krystal Biotech's Cash from Investing Activities rose 87.51% to -$4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$153.4 million, marking a year-over-year decrease of 70.74%. This contributed to the annual value of -$163.4 million for FY2024, which is 297.78% down from last year.
  • According to the latest figures from FY2024, Krystal Biotech's Cash from Investing Activities is -$163.4 million, which was down 297.78% from $82.6 million recorded in FY2023.
  • Over the past 5 years, Krystal Biotech's Cash from Investing Activities peaked at $82.6 million during FY2023, and registered a low of -$226.8 million during FY2021.
  • For the 3-year period, Krystal Biotech's Cash from Investing Activities averaged around -$65.0 million, with its median value being -$114.1 million (2022).
  • As far as peak fluctuations go, Krystal Biotech's Cash from Investing Activities crashed by 1,928.17% in 2021, and later spiked by 172.44% in 2023.
  • Over the past 5 years, Krystal Biotech's Cash from Investing Activities (Yearly) stood at -$11.2 million in 2020, then crashed by 1,928.17% to -$226.8 million in 2021, then skyrocketed by 49.69% to -$114.1 million in 2022, then soared by 172.44% to $82.6 million in 2023, then tumbled by 297.78% to -$163.4 million in 2024.